# Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)

> **NCT00750750** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 981 (actual)

## Conditions studied

- Acute Rhinosinusitis

## Interventions

- **DRUG:** mometasone furoate nasal spray (MFNS)
- **DRUG:** MFNS
- **DRUG:** Amoxicillin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00750750
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01-01
- **Primary completion:** 2003-09-01
- **Final completion:** 2003-09-01
- **Target enrollment:** 981 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750750, "Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00750750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*